76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas
Publication
, Conference
Hurwitz, H; Pitot, H; Strickler, J; Sorensen, JM; Leopold, L; Brill, J; Smith, DC
Published in: European Journal of Cancer
November 2012
Duke Scholars
Published In
European Journal of Cancer
DOI
ISSN
0959-8049
Publication Date
November 2012
Volume
48
Start / End Page
25 / 25
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Hurwitz, H., Pitot, H., Strickler, J., Sorensen, J. M., Leopold, L., Brill, J., & Smith, D. C. (2012). 76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas. In European Journal of Cancer (Vol. 48, pp. 25–25). Elsevier BV. https://doi.org/10.1016/s0959-8049(12)71874-9
Hurwitz, H., H. Pitot, J. Strickler, J. M. Sorensen, L. Leopold, J. Brill, and D. C. Smith. “76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas.” In European Journal of Cancer, 48:25–25. Elsevier BV, 2012. https://doi.org/10.1016/s0959-8049(12)71874-9.
Hurwitz H, Pitot H, Strickler J, Sorensen JM, Leopold L, Brill J, et al. 76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas. In: European Journal of Cancer. Elsevier BV; 2012. p. 25–25.
Hurwitz, H., et al. “76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas.” European Journal of Cancer, vol. 48, Elsevier BV, 2012, pp. 25–25. Crossref, doi:10.1016/s0959-8049(12)71874-9.
Hurwitz H, Pitot H, Strickler J, Sorensen JM, Leopold L, Brill J, Smith DC. 76 Preliminary Report of a First-in-human, Open-label, Multicenter, Phase I Study of AT-406 (Debio 1143), an Oral Small Molecule Multi-IAP Inhibitor, in Solid Tumors and Lymphomas. European Journal of Cancer. Elsevier BV; 2012. p. 25–25.
Published In
European Journal of Cancer
DOI
ISSN
0959-8049
Publication Date
November 2012
Volume
48
Start / End Page
25 / 25
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis